- Home
- ACOG vs TNYA Comparison
ACOG vs TNYA Comparison
Compare ACOG & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACOG
- TNYA
- Stock Information
- Founded
- ACOG 2000
- TNYA 2016
- Country
- ACOG Canada
- TNYA United States
- Employees
- ACOG N/A
- TNYA N/A
- Industry
- ACOG
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- ACOG
- TNYA Health Care
- Exchange
- ACOG Nasdaq
- TNYA Nasdaq
- Market Cap
- ACOG 80.3M
- TNYA 73.8M
- IPO Year
- ACOG N/A
- TNYA 2021
- Fundamental
- Price
- ACOG $10.35
- TNYA $0.69
- Analyst Decision
- ACOG Strong Buy
- TNYA Strong Buy
- Analyst Count
- ACOG 1
- TNYA 5
- Target Price
- ACOG $20.00
- TNYA $8.60
- AVG Volume (30 Days)
- ACOG 62.9K
- TNYA 2.3M
- Earning Date
- ACOG 08-14-2025
- TNYA 08-07-2025
- Dividend Yield
- ACOG N/A
- TNYA N/A
- EPS Growth
- ACOG N/A
- TNYA N/A
- EPS
- ACOG N/A
- TNYA N/A
- Revenue
- ACOG $2,928,654.00
- TNYA N/A
- Revenue This Year
- ACOG N/A
- TNYA N/A
- Revenue Next Year
- ACOG N/A
- TNYA N/A
- P/E Ratio
- ACOG N/A
- TNYA N/A
- Revenue Growth
- ACOG N/A
- TNYA N/A
- 52 Week Low
- ACOG $3.75
- TNYA $0.36
- 52 Week High
- ACOG $11.54
- TNYA $4.06
- Technical
- Relative Strength Index (RSI)
- ACOG N/A
- TNYA 60.54
- Support Level
- ACOG N/A
- TNYA $0.58
- Resistance Level
- ACOG N/A
- TNYA $0.70
- Average True Range (ATR)
- ACOG 0.00
- TNYA 0.05
- MACD
- ACOG 0.00
- TNYA 0.00
- Stochastic Oscillator
- ACOG 0.00
- TNYA 64.50
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.